GLA:D® Back: Patient Education and Exercises for Self-management of Back Pain

November 28, 2023 updated by: Alice Kongsted, University of Southern Denmark

GLA:D® Back: Implementation of Group-based Patient Education and Exercises to Support Self-management of Back Pain

The GLA:D Back project evaluates the implementation of standardised patient education and exercise therapy for people with persistent or recurrent low back pain (LBP) in a hybrid implementation-effectiveness design. This involves evaluating the process of implementation as well as clinician level outcomes and patient level outcomes.

GLA:D (Good Life with OsteoArthritis in Denmark) is a non-profit initiative and registered trademark from the University of Southern Denmark. It educates clinicians in delivering evidence-based care for musculoskeletal health conditions and registers outcomes in a clinical registry. GLA:D Back uses only the acronym.

The main activity of the implementation strategy is a two-days course for physiotherapists and chiropractors in delivering patient education and exercise therapy that is aimed at supporting patient self-management of LBP. This comes with ready-to-use patient education materials and exercise programs. The course is targeted at chiropractors and physiotherapists, but any health care provider authorised to treat patients with back pain in Denmark can participate, i.e. medical doctors, physiotherapists and chiropractors.

The clinical intervention is a group-based program consisting of two sessions of patient education and 8 weeks of supervised exercises. The program uses a cognitive-behavioural approach and the aim of the exercise component is to restore the patient's ability and confidence to move freely. Clinicians decide which patients are offered the program.

The implementation process is evaluated in a dynamic process monitoring the penetration, adoption and fidelity of the clinical intervention.

The education of clinicians is evaluated via clinician-level outcomes concerning attitudes towards back pain and confidence in managing people with LBP.

The clinical intervention and potential effect mechanisms are evaluated at the patient-level in an observational design. Patients who are participating in the GLA:D Back program are followed using measures of knowledge, skills, beliefs, performance, self-efficacy and success in self-management.

Effects at a national level will be investigated via data from national registries of health care utilisation and sick-leave. Patient- and clinician reported data are collected in a registry.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The clinician training courses are open to all interested authorised back pain clinicians practicing in Denmark. The study evaluates courses conducted in 2018 which involves one or two courses for clinicians in each of five Danish regions.

The adoption of GLA:D Back is investigated by measuring the extent to which clinicians who have participated in the GLA:D Back course conduct the program in their clinics. Reach of the patient target group is determined by asking clinicians about the degree to which patients offered the treatment accept this. Fidelity with the program is investigated quantitatively by asking about treatment content and recall of key messages via patient questionnaires, and by ensuring that patients' individual goals are registered. The quality of care in terms of delivering the key elements of the intervention will be further explored qualitatively.

The profile of patients enrolled in the GLA:D Back programme will be compared between clinics and administrative regions.

Clinician level effects are investigated in an observational longitudinal design with clinician reported data collected before the clinician training course, immediately after the course and 4 months later, and with patient-reported information on delivery collected at their three-months follow up. Indicators of implementation are registration of patients in the GLA:D Back registry and that patients report receiving the educational components of care and supervised exercises. Orientation towards treatment of LBP and confidence in managing patients with LBP are evaluated by clinicians' answers to standardised questionnaires.

Patient level outcomes are aimed at investigating changes in knowledge, beliefs and skills related to the LBP condition which is hypothesized to lead to improved self-efficacy. The initial measures are related to knowledge skills, beliefs and performance, the next line of outcomes to self-efficacy, then daily activities and quality of life and last health care utilisation and work ability.

The compliance with the program is evaluated by patient report of the number of patient education sessions and exercise sessions attended.

The registry is delivered by Odense Patient data Explorative Network (OPEN) at University of Southern Denmark and uses REDCap (Vanderbilt University) as the platform for data collection. Clinicians are registered when signing up for the GLA:D Back course and agreeing to participate in research. Patients are registered by the clinician and have links to patient questionnaires sent to their email before beginning the GLA:D Back program and after 3, 6 and 12 months if consenting to their data being used for research.

Rather than testing effects on one primary outcome, the study evaluates the implementation process and a number of outcomes based on a logical model of change.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Odense, Denmark, 5230
        • Recruiting
        • University of Southern Denmark (central unit)
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participants are people consulting a physiotherapist or chiropractor who are trained in the GLA:D Back program. The decision to enrol a patient in GLA:D Back is at the discretion of the clinician in a dialogue with the patient, when clinicians judge that the patient would benefit from improved self-management skills

Description

Inclusion Criteria:

The decision to invite a patient to participate in the GLA:D Back program is at the discretion of the clinician. Clinicians are taught that the program was developed for people with persistent or recurrent low back pain and a need for improved self-management

Exclusion Criteria:

Back pain related to specific spinal or systemic pathology, signs of acute nerve root involvement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
GLA:D Back
Two 1-hour group sessions of patient education 8 weeks of twice-weekly 1-hour supervised group exercise sessions
The intervention aims at improving the participant's ability to self-manage low back pain (LBP). The content is based on a cognitive behavioural approach aimed at supporting pain self-efficacy. An individual session at the beginning and the end of the group sessions involve goal-setting and physical tests. Key messages of the patient education include that pain is not a sign of danger and back pain is explained using a behavioural model of (im)balance between demands and capacity rather than emphasising tissue damage. The exercises aim at restoring natural variation in movement and provides guidance for patients in exploring movement rather than teaching exercises in only one correct manner.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Brief Illness Perceptions Questionnaire (B-IPQ)
Time Frame: Change from baseline to 3 months
Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause. Each of the items 1 to 8 are scored 0 - 10. If internal consistency allows so a sum score is calculated (0-80). Cause is registered as text.
Change from baseline to 3 months
Fear Avoidance Beliefs Questionnaire (FABQ)
Time Frame: Change from baseline to 3 months
FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)
Change from baseline to 3 months
The Arthritis Self-efficacy (ASES)
Time Frame: Change from baseline to 6 months
ASES subscales of pain and other symptoms. Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)
Change from baseline to 6 months
Quality of Life (General health)
Time Frame: Proportions in response categories baseline to 12 months
The 36-Item Short Form Health Survey (SF-36 item1); 5-point likert scale
Proportions in response categories baseline to 12 months
Quality of Life (Social functioning)
Time Frame: Change from baseline to 12 months
The 36-Item Short Form Health Survey (SF-36) subdomain social functioning, transformed score 0-100
Change from baseline to 12 months
Quality of Life (Mental functioning)
Time Frame: Change from baseline to 12 months
The 36-Item Short Form Health Survey (SF-36) subdomain mental functioning, transformed score 0-100
Change from baseline to 12 months
General Health
Time Frame: Change from baseline to 12 months
Health thermometer from Eq-5D, score 0= worst imaginable to 100= best imaginable
Change from baseline to 12 months
Health care visits primary care
Time Frame: During 12 months after participation
Number of primary care visits from national registries
During 12 months after participation
Health care visits hospital
Time Frame: During 12 months after participation
Number of hospital visits due to LBP from national registries
During 12 months after participation
Imaging
Time Frame: During 12 months after participation
x-rays, MRI and CT-scans of lower back from national registries
During 12 months after participation
Pain medication
Time Frame: During 12 months after participation
Prescriptions of pain medication from national registries
During 12 months after participation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Confidence with exercises
Time Frame: Change from baseline to 3 months
How confident are you in performing exercises in a beneficial way?' (0-10 scale from 'not confident at all' to 'absolutely confident')
Change from baseline to 3 months
Self-assessed physical capacity
Time Frame: Change from baseline to 3 months
Self-assessed physical fitness visual analogue scales on perceived strength, endurance, flexibility, balance, and moving unhindered as compared with that of other people of the same age and sex. Each item is scored on a 9-point scale (1 = poor; 5 = average; 9 = super). Each item is treated as one subscale
Change from baseline to 3 months
Satisfaction with care
Time Frame: 3 months
Overall satisfaction with care (5-point Likert scale; 0 = Not at all satisfied, 5 = Extremely satisfied)
3 months
Patient reported harms or side effects
Time Frame: 3 months
Text description of any side effects or problems experienced in relation to the participation in GLA:D Back.
3 months
Oswestry Disability Index
Time Frame: Change from baseline to 3, 6, 12 months
Ten items, sum score 0 - 50 recalculated to 0-100 (0 = No disability; 100 = Maximum disability)
Change from baseline to 3, 6, 12 months
Pain Intensity
Time Frame: Change from baseline to 3, 6, 12 months
Numeric Rating Scale 0-10 for typical back pain last week (0 = no pain; 10 = worst imaginable pain)
Change from baseline to 3, 6, 12 months
Work ability
Time Frame: During 12 months after participation
Number of days off work after 1 month of absenteeism available from the 'DREAM' registry from the Danish Ministry of Employment
During 12 months after participation
Brief Illness Perceptions Questionnaire (B-IPQ)
Time Frame: Change from baseline to 6, 12 months
Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause. Each of the items 1 to 8 are scored 0 - 10. If internal consistency allows so a sum score is calculated (0-80). Cause is registered as text.
Change from baseline to 6, 12 months
Fear Avoidance Beliefs Questionnaire (FABQ)
Time Frame: Change from baseline to 6, 12 months
FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)
Change from baseline to 6, 12 months
The Arthritis Self-efficacy (ASES)
Time Frame: Change from baseline to 3, 12 months
ASES subscales of pain and other symptoms. Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)
Change from baseline to 3, 12 months
Quality of Life (General Health)
Time Frame: Proportions in response categories baseline to 3, 6 months
The 36-Item Short Form Health Survey (SF-36 item 1),5-point Likert scale
Proportions in response categories baseline to 3, 6 months
Quality of Life (Social functioning)
Time Frame: Change from baseline to 3, 6 months
The 36-Item Short Form Health Survey (SF-36) subdomains social functioning, transformed score 0-100
Change from baseline to 3, 6 months
Quality of Life /Mental functioning)
Time Frame: Change from baseline to 3, 6 months
The 36-Item Short Form Health Survey (SF-36) subdomains of mental functioning, transformed score 0-100
Change from baseline to 3, 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Pain Attitudes and Beliefs Scale for Physiotherapists (PABS-PT)
Time Frame: Change from before course participation to 4 months
Clinician reported 19-item scale. Two subscales: biomedical orientation and behavioural orientation are scored
Change from before course participation to 4 months
Practitioner Confidence Scale (PCS)
Time Frame: Change from before course participation to 4 months
Clinician reported 4-item scale plus two items added to capture confidence about using a behavioral pain model
Change from before course participation to 4 months
The Determinants of Implementation Behavior Questionnaire (DIBQ)
Time Frame: Immediately after curse participation and 4 months
Clinician level measure of the implementation process. Thirty-one items from the domains of knowledge, skills, beliefs about capability, beliefs about consequences, innovation, patients, intentions, organisation, social influences, social context, behavioural regulation, and innovation strategy
Immediately after curse participation and 4 months
Adoption
Time Frame: Within 6 months
Proportion of clinicians participating in a GLA:D Back course that delivers the program
Within 6 months
Patients participation
Time Frame: 4 months
Clinician reported proportion of invited patients who decide to participate
4 months
Patient compliance
Time Frame: 3 months
Proportion of patients enrolled in GLA:D Back that complete the program
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alice Kongsted, PhD, University of Southern Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2018

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

May 31, 2018

First Submitted That Met QC Criteria

June 15, 2018

First Posted (Actual)

June 27, 2018

Study Record Updates

Last Update Posted (Estimated)

December 5, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DPA 2015-57-0008 SDU 17/30591

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Back Pain, Low

Clinical Trials on GLA:D Back

3
Subscribe